Related Experiment Video

Updated: Jun 5, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

How to use virological tools for the optimal management of chronic hepatitis C

Philipp de Leuw1, Christoph Sarrazin, Stefan Zeuzem

  • 1Medizinische Klinik I, Klinikum der Johann-Wolfgang Goethe-Universität, Frankfurt am Main, Germany.

Liver International : Official Journal of the International Association for the Study of the Liver
|January 6, 2011
PubMed

Insights

Hepatitis C virus (HCV) genotyping is crucial for effective antiviral therapy, guiding treatment duration and drug dosage. Monitoring HCV RNA levels ensures optimal treatment response and individualized strategies for chronic hepatitis C management.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Medicine

Background:

  • Chronic hepatitis C virus (HCV) infection affects approximately 180 million people globally.
  • HCV infection is a major cause of cirrhosis, end-stage liver disease, and hepatocellular carcinoma.
  • Effective management of HCV requires robust virological monitoring tools.

Purpose of the Study:

  • To highlight the importance of HCV genotyping in guiding antiviral therapy.
  • To emphasize the role of HCV RNA monitoring in response-guided treatment.
  • To underscore the need for individualized treatment strategies in chronic hepatitis C.

Main Methods:

  • Utilizing anti-HCV antibody assays for diagnosis.
  • Measuring HCV RNA levels with sensitive assays (limit of detection ≤ 15 IU/ml).
  • Performing HCV genotyping for therapeutic decision-making.

Main Results:

  • HCV genotype determination influences recommended treatment duration and ribavirin dosage.
  • HCV subtyping is increasingly important for direct-acting antiviral (DAA) therapies due to varying efficacy and resistance profiles.
  • Monitoring HCV RNA enables response-guided therapy with pegylated interferon plus ribavirin.

Conclusions:

  • HCV genotyping is essential for optimizing antiviral treatment regimens.
  • Sensitive HCV RNA monitoring is fundamental for individualized, response-guided therapy.
  • Established rules for treatment discontinuation and duration optimize outcomes in chronic hepatitis C patients.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...